Silk Road Medical, Inc (SILK)

USD 27.49

(-0.04%)

Market Cap (In USD)

1.11 Billion

Revenue (In USD)

177.13 Million

Net Income (In USD)

-55.74 Million

Avg. Volume

2.06 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
6.08-27.51
PE
-
EPS
-
Beta Value
1.538
ISIN
US82710M1009
CUSIP
82710M100
CIK
1397702
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Charles S. McKhann
Employee Count
-
Website
https://silkroadmed.com
Ipo Date
2019-04-04
Details
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.